Detalles de la búsqueda
1.
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study.
Blood;
139(15): 2338-2346, 2022 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34936697
2.
Does early disease progression predict survival after first line-treatment of Waldenström macroglobulinemia?
Hematol Oncol;
40(3): 400-408, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385885
3.
A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohort.
BMC Public Health;
21(1): 432, 2021 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33653294
4.
Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia.
BMC Cancer;
19(1): 809, 2019 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31412798
5.
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centers.
Am J Hematol;
2018 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29884994
6.
A single center evaluation of cost savings related to treatment-free remission in chronic myeloid leukemia patients: the prerequisites of a pharmaco-economy larger study.
Br J Haematol;
189(3): e97-e100, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043283
7.
Neonatal sex and weight influence CD34(+) cell concentration in umbilical cord blood but not stromal cell-derived factor 1-3'A polymorphism.
Cytotherapy;
17(1): 68-72, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25446160
8.
A nationwide survey of the use of plerixafor in patients with lymphoid malignancies who mobilize poorly demonstrates the predominant use of the "on-demand" scheme of administration at French autologous hematopoietic stem cell transplant programs.
Transfusion;
55(9): 2149-57, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25968564
9.
JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone.
Blood;
120(13): 2704-7, 2012 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22898600
10.
Cerebellum/liver index on baseline 18F-FDG PET/CT to improve prognostication in post-transplant lymphoproliferative disorders: a multicenter retrospective study.
EJNMMI Res;
14(1): 49, 2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38801646
11.
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Blood Adv;
8(2): 296-308, 2024 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37874913
12.
Baseline 18F-FDG Metabolic Tumor Volume Predicts Response to Rituximab Induction in Post-transplant Lymphoproliferative Disorders: A Multi-institutional Retrospective Study.
Hemasphere;
7(2): e833, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36713354
13.
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma.
J Clin Oncol;
41(33): 5107-5117, 2023 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37506346
14.
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group.
Blood Adv;
7(19): 5733-5742, 2023 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36477770
15.
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study.
Blood Adv;
7(22): 6801-6811, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37682792
16.
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
J Clin Oncol;
41(19): 3523-3533, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37071836
17.
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY.
EClinicalMedicine;
65: 102307, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38033506
18.
Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients.
Cancers (Basel);
14(8)2022 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35454811
19.
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma.
EJHaem;
3(2): 394-405, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35846031
20.
STAT1 activation in association with JAK2 exon 12 mutations.
Haematologica;
101(1): e15-9, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26635038